TrialThe Lancet. Oncology2014

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.

Hans-Joachim Schmoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.